Ars Pharms Operation Drug Patent Portfolio
Ars Pharms Operation owns 1 orange book drug protected by 7 US patents Given below is the list of Ars Pharms Operation's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10682414 | Intranasal epinephrine formulations and methods for the treatment of disease | 06 Feb, 2039 | Active |
| US11191838 | Intranasal epinephrine formulations and methods for the treatment of disease | 06 Feb, 2039 | Active |
| US11717571 | Intranasal epinephrine formulations and methods for the treatment of disease | 06 Feb, 2039 | Active |
| US11744895 | Intranasal epinephrine formulations and methods for the treatment of disease | 06 Feb, 2039 | Active |
| US11918655 | Intranasal epinephrine formulations and methods for the treatment of disease | 06 Feb, 2039 | Active |
| US10576156 | Compositions for drug administration | 06 Feb, 2038 | Active |
| US11173209 | Compositions for drug administration | 06 Feb, 2038 | Active |
Ars Pharms Operation's Family Patents
Ars Pharms Operation Drug List
Given below is the complete list of Ars Pharms Operation's drugs and the patents protecting them.
1. Neffy
Neffy is protected by 7 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10682414 | Intranasal epinephrine formulations and methods for the treatment of disease |
06 Feb, 2039
(14 years from now)
| Active |
| US11191838 | Intranasal epinephrine formulations and methods for the treatment of disease |
06 Feb, 2039
(14 years from now)
| Active |
| US11717571 | Intranasal epinephrine formulations and methods for the treatment of disease |
06 Feb, 2039
(14 years from now)
| Active |
| US11744895 | Intranasal epinephrine formulations and methods for the treatment of disease |
06 Feb, 2039
(14 years from now)
| Active |
| US11918655 | Intranasal epinephrine formulations and methods for the treatment of disease |
06 Feb, 2039
(14 years from now)
| Active |
| US10576156 | Compositions for drug administration |
06 Feb, 2038
(13 years from now)
| Active |
| US11173209 | Compositions for drug administration |
06 Feb, 2038
(13 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Neffy's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List